Updated on 10 September 2026
Real-Time Patient Telemonitoring & RTLS Technology for Oncology Care
Head of IoT Intelligent Solutions at Softgent Sp. z o. o.
Gdansk, Poland
About
What we offer
Softgent brings field-deployed, production-proven Healthcare IoT technology to your Horizon Europe consortium:
· EMERGENT — real-time patient location tracking and vital signs telemonitoring, already running in emergency departments, oncology units and senior living facilities. Delivers real-time alerts and continuous monitoring to support earlier intervention and safer, more person-centred care, including in home-based settings.
· TRACKGENT — a scalable UWB-based Real-Time Location System (RTLS) for precise tracking of equipment, assets and personnel in hospitals and Comprehensive Cancer Centres.
· PROXIGENT — an intelligent hand-hygiene compliance solution supporting infection-prevention protocols.
All three products are commercially deployed today — not lab prototypes. Softgent is ISO 9001:2015 and ISO/IEC 27001:2022 certified, with development processes aligned to ISO 13485 (medical devices) and NIS2 (cybersecurity), meeting the quality and regulatory bar expected in EU-funded healthcare projects
Topic
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
Type
- Partner seeks Consortium/Coordinator
Attached files
Organisation
Similar opportunities
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-04
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Birute Brasiuniene
MD PhD Head of the Center of Medical oncology at National Cancer Center of VULSK at National Cancer Center branch of Vilnius University hospital Santaros clinics
Vilnius, Lithuania
Project cooperation
Health Economics & Value Demonstration Partner for MedTech and Healthcare Innovation Consortia
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Rhodri Saunders
CEO at Coreva Scientific
Königswinter, Germany
Project cooperation
Expertise in HORIZON-MISS-2027-02-CANCER-04
- Partner seeks Consortium/Coordinator
- Healthcare innovations: HORIZON-MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
Rita Kupcinskaite
Medical Oncologist/Associate professor/ Lead of Tumor Molecular Board at Lithuanian university of health sciences
Kaunas, Lithuania